Cavitation Technologies, Inc.
For the period ended Jun 30, 2026. Filed Oct 6, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Oct 6, 2026
Contents
Item 9B. Other Information
During the quarter ended June 30, 2026, no director or officer adopted orterminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.
We do not maintain insider trading policies and procedures governing the purchase, sale, and/or other dispositions of our securities by our directors, officers, and employees that we believe are reasonably designed to promote compliance with insider trading laws, rules, and regulations applicable to us. We have failed to do so due to limited number of members of management, limited resources, and the limited equity awards granted to management.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.